GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Ishita Drugs And Industries Ltd (BOM:524400) » Definitions » Beneish M-Score

Ishita Drugs And Industries (BOM:524400) Beneish M-Score : -3.24 (As of Apr. 10, 2025)


View and export this data going back to 1994. Start your Free Trial

What is Ishita Drugs And Industries Beneish M-Score?

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Good Sign:

Beneish M-Score -3.24 no higher than -1.78, which implies that the company is unlikely to be a manipulator.

The historical rank and industry rank for Ishita Drugs And Industries's Beneish M-Score or its related term are showing as below:

BOM:524400' s Beneish M-Score Range Over the Past 10 Years
Min: -4.3   Med: -2.48   Max: 1.69
Current: -3.24

During the past 13 years, the highest Beneish M-Score of Ishita Drugs And Industries was 1.69. The lowest was -4.30. And the median was -2.48.


Ishita Drugs And Industries Beneish M-Score Historical Data

The historical data trend for Ishita Drugs And Industries's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ishita Drugs And Industries Beneish M-Score Chart

Ishita Drugs And Industries Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Beneish M-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only -2.28 -1.40 -4.30 1.69 -3.24

Ishita Drugs And Industries Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Beneish M-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - -3.24 - - -

Competitive Comparison of Ishita Drugs And Industries's Beneish M-Score

For the Drug Manufacturers - Specialty & Generic subindustry, Ishita Drugs And Industries's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Ishita Drugs And Industries's Beneish M-Score Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Ishita Drugs And Industries's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where Ishita Drugs And Industries's Beneish M-Score falls into.


;
;

Ishita Drugs And Industries Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of Ishita Drugs And Industries for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 0.2779+0.528 * 1.1127+0.404 * 1.0771+0.892 * 1.2581+0.115 * 1.0411
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 1.1127+4.679 * -0.126963-0.327 * 0.4136
=-3.24

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Mar24) TTM:Last Year (Mar23) TTM:
Total Receivables was ₹7.0 Mil.
Revenue was ₹151.9 Mil.
Gross Profit was ₹34.8 Mil.
Total Current Assets was ₹96.6 Mil.
Total Assets was ₹108.1 Mil.
Property, Plant and Equipment(Net PPE) was ₹8.0 Mil.
Depreciation, Depletion and Amortization(DDA) was ₹1.1 Mil.
Selling, General, & Admin. Expense(SGA) was ₹9.1 Mil.
Total Current Liabilities was ₹8.7 Mil.
Long-Term Debt & Capital Lease Obligation was ₹0.0 Mil.
Net Income was ₹7.5 Mil.
Gross Profit was ₹0.0 Mil.
Cash Flow from Operations was ₹21.2 Mil.
Total Receivables was ₹20.0 Mil.
Revenue was ₹120.7 Mil.
Gross Profit was ₹30.7 Mil.
Total Current Assets was ₹101.8 Mil.
Total Assets was ₹114.1 Mil.
Property, Plant and Equipment(Net PPE) was ₹8.9 Mil.
Depreciation, Depletion and Amortization(DDA) was ₹1.3 Mil.
Selling, General, & Admin. Expense(SGA) was ₹6.5 Mil.
Total Current Liabilities was ₹22.1 Mil.
Long-Term Debt & Capital Lease Obligation was ₹0.0 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(7.002 / 151.876) / (20.028 / 120.723)
=0.046103 / 0.1659
=0.2779

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(30.739 / 120.723) / (34.754 / 151.876)
=0.254624 / 0.228831
=1.1127

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (96.57 + 8.046) / 108.087) / (1 - (101.776 + 8.895) / 114.072)
=0.032113 / 0.029815
=1.0771

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=151.876 / 120.723
=1.2581

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(1.293 / (1.293 + 8.895)) / (1.117 / (1.117 + 8.046))
=0.126914 / 0.121903
=1.0411

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(9.086 / 151.876) / (6.491 / 120.723)
=0.059825 / 0.053768
=1.1127

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((0 + 8.673) / 108.087) / ((0 + 22.13) / 114.072)
=0.080241 / 0.194
=0.4136

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(7.485 - 0 - 21.208) / 108.087
=-0.126963

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Ishita Drugs And Industries has a M-score of -3.24 suggests that the company is unlikely to be a manipulator.


Ishita Drugs And Industries Beneish M-Score Related Terms

Thank you for viewing the detailed overview of Ishita Drugs And Industries's Beneish M-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


Ishita Drugs And Industries Business Description

Traded in Other Exchanges
N/A
Address
C.G.Road, 401, 3rd Eye -II, Opposite Parimal Garden, Ahmedabad, GJ, IND, 380006
Ishita Drugs And Industries Ltd is engaged in the business of manufacturing various APIs and drug intermediates. It manufactures high quality products and is known for its ethical dealings in business. The company supplies its products to various pharmaceutical companies and is also being exported to various countries across the world. The company has three manufacturing facilities located in the state of Gujarat, two for APIs and drug intermediates at Ahmedabad and Surendranagar and one for finished pharmaceutical formulations at Mehsana.

Ishita Drugs And Industries Headlines

No Headlines